Tissue kallikrein effectively activates latent matrix degrading metalloenzymes

Tschesche H, Michaelis J, Kohnert U, Fedrowitz J, Oberhoff R (1989)
Adv Exp Med Biol 247A(3): 280-284.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Tschesche, HaraldUniBi; Michaelis, J; Kohnert, U; Fedrowitz, J; Oberhoff, R
Einrichtung
Fakultät für Chemie > Biochemie I
Erscheinungsjahr
1989
Zeitschriftentitel
Adv Exp Med Biol
Band
247A
Ausgabe
3
Seite(n)
280-284
ISSN
0065-2598
Page URI
https://pub.uni-bielefeld.de/record/1948420

Zitieren

Tschesche H, Michaelis J, Kohnert U, Fedrowitz J, Oberhoff R. Tissue kallikrein effectively activates latent matrix degrading metalloenzymes. Adv Exp Med Biol. 1989;247A(3):280-284.
Tschesche, H., Michaelis, J., Kohnert, U., Fedrowitz, J., & Oberhoff, R. (1989). Tissue kallikrein effectively activates latent matrix degrading metalloenzymes. Adv Exp Med Biol, 247A(3), 280-284.
Tschesche, Harald, Michaelis, J, Kohnert, U, Fedrowitz, J, and Oberhoff, R. 1989. “Tissue kallikrein effectively activates latent matrix degrading metalloenzymes”. Adv Exp Med Biol 247A (3): 280-284.
Tschesche, H., Michaelis, J., Kohnert, U., Fedrowitz, J., and Oberhoff, R. (1989). Tissue kallikrein effectively activates latent matrix degrading metalloenzymes. Adv Exp Med Biol 247A, 280-284.
Tschesche, H., et al., 1989. Tissue kallikrein effectively activates latent matrix degrading metalloenzymes. Adv Exp Med Biol, 247A(3), p 280-284.
H. Tschesche, et al., “Tissue kallikrein effectively activates latent matrix degrading metalloenzymes”, Adv Exp Med Biol, vol. 247A, 1989, pp. 280-284.
Tschesche, H., Michaelis, J., Kohnert, U., Fedrowitz, J., Oberhoff, R.: Tissue kallikrein effectively activates latent matrix degrading metalloenzymes. Adv Exp Med Biol. 247A, 280-284 (1989).
Tschesche, Harald, Michaelis, J, Kohnert, U, Fedrowitz, J, and Oberhoff, R. “Tissue kallikrein effectively activates latent matrix degrading metalloenzymes”. Adv Exp Med Biol 247A.3 (1989): 280-284.

19 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

The role of kinin receptors in cancer and therapeutic opportunities.
da Costa PL, Sirois P, Tannock IF, Chammas R., Cancer Lett. 345(1), 2014
PMID: 24333733
Deciphering c-MYC-regulated genes in two distinct tissues.
Robson SC, Ward L, Brown H, Turner H, Hunter E, Pelengaris S, Khan M., BMC Genomics 12(), 2011
PMID: 21961992
Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart.
Campbell DJ, Zhang Y, Kelly DJ, Gilbert RE, McCarthy DJ, Shi W, Smyth GK., Clin. Exp. Pharmacol. Physiol. 38(9), 2011
PMID: 21736602
Role of human tissue kallikrein in gastrointestinal stromal tumour invasion.
Dominek P, Campagnolo P, H-Zadeh M, Krankel N, Chilosi M, Sharman JA, Caporali A, Mangialardi G, Spinetti G, Emanueli C, Pignatelli M, Madeddu P., Br. J. Cancer 103(9), 2010
PMID: 20859288
Kallikrein-related peptidases: bridges between immune functions and extracellular matrix degradation.
Sotiropoulou G, Pampalakis G., Biol. Chem. 391(4), 2010
PMID: 20180637
Helping the circulatory system heal itself: manipulating kinin signaling to promote neovascularization.
Krankel N, Madeddu P., Expert Rev Cardiovasc Ther 7(3), 2009
PMID: 19296754
Expression of tissue and plasma kallikreins and kinin B1 and B2 receptors in lung cancer.
Chee J, Naran A, Misso NL, Thompson PJ, Bhoola KD., Biol. Chem. 389(9), 2008
PMID: 18713009
Kallikrein inhibitors limit kinin B(2) antagonist-induced progression of oedematous to haemorrhagic pancreatitis in rats.
Griesbacher T, Rainer I, Tiran B, Peskar BA., Br. J. Pharmacol. 155(6), 2008
PMID: 18695645
Novel expression of kallikreins, kallikrein-related peptidases and kinin receptors in human pleural mesothelioma.
Chee J, Singh J, Naran A, Misso NL, Thompson PJ, Bhoola KD., Biol. Chem. 388(11), 2007
PMID: 17976017
Spatio-temporal expression of MMP-2, MMP-9 and tissue kallikrein in uteroplacental units of the pregnant guinea-pig (Cavia porcellus).
Corthorn J, Rey S, Chacon C, Valdes G., Reprod. Biol. Endocrinol. 5(), 2007
PMID: 17605824
Tissue kallikrein and kinin receptor expression in an angiogenic co-culture neuroblastoma model.
Naidoo S, Raidoo DM., Metab Brain Dis 21(2-3), 2006
PMID: 16865540
The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition.
Whitbread AK, Veveris-Lowe TL, Lawrence MG, Nicol DL, Clements JA., Biol. Chem. 387(6), 2006
PMID: 16800731
The emerging roles of human tissue kallikreins in cancer.
Borgono CA, Diamandis EP., Nat. Rev. Cancer 4(11), 2004
PMID: 15516960
Tumour metabolites regulate tissue kallikrein in human umbilical vein endothelial cells.
Naidoo S, Raidoo D, Mahabeer R, McLean M., Biochim. Biophys. Acta 1691(2-3), 2004
PMID: 15110992
Kallikrein cascade and cytokines in inflamed joints.
Cassim B, Mody G, Bhoola K., Pharmacol. Ther. 94(1-2), 2002
PMID: 12191591
The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions.
Clements J, Hooper J, Dong Y, Harvey T., Biol. Chem. 382(1), 2001
PMID: 11258672
Visualization of tissue kallikrein in human breast carcinoma by two-dimensional western blotting and immunohistochemistry.
Hermann A, Buchinger P, Rehbock J., Biol. Chem. Hoppe-Seyler 376(6), 1995
PMID: 7576230
Identification of immunoreactive tissue kallikrein in human ductal breast carcinomas.
Rehbock J, Buchinger P, Hermann A, Figueroa C., J. Cancer Res. Clin. Oncol. 121(1), 1995
PMID: 7860622
Kallikreins and kinins: mediators in inflammatory joint disease?
Worthy K, Figueroa CD, Dieppe PA, Bhoola KD., Int J Exp Pathol 71(4), 1990
PMID: 2205284
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Quellen

PMID: 2557753
PubMed | Europe PMC

Suchen in

Google Scholar